Hepatitis C: The Basics

Published Online: Friday, February 24, 2012
Follow Pharmacy_Times:
Hepatitis C is a viral disease spread via blood that affects liver function and can lead to cirrhosis, cancer, and death. Risk factors include receiving blood transfusions or organ transplants before 1992, sharing intravenous drug needles or cocaine straws, engaging in rough sex, and receiving tattoos or piercings from unsterilized equipment. Unlike hepatitis A and B, there is no vaccine for hepatitis C. It can be cured through treatment, however, so it is important for those with risk factors to learn whether they have it.
 
Check out this video to learn more:

Related Articles
The Bristol-Myers Squibb Foundation today announced nine new grants totaling more than $3.5 million to strengthen efforts in China and India in the fight against hepatitis B virus and hepatitis C virus infection by focusing on the most vulnerable, high-risk patient populations.
A study from Merck has demonstrated high response to grazoprevir/elbasvir with and without ribavirin across various hepatitis C virus populations, including difficult-to-cure patients.
The drugmaker will no longer pursue FDA approval of its dual daclatasvir and asunaprevir treatment for patients with hepatitis C virus genotype 1b.
Researchers from Saint Louis University Medical Center will test the safety and efficacy of sofosbuvir and ribavirin in children with hepatitis C.
Latest Issues
$auto_registration$